53 results
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
Opportunistic Disease in HIV-AIDS ... Papillomavirus (HPV ... Hepatitis A virus (HAV ... Infections #OIs #HIVAIDS ... #IDSA #management
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
Opportunistic Disease in HIV-AIDS ... Papillomavirus (HPV ... Hepatitis A virus (HAV ... Infections #OIs #HIVAIDS ... #IDSA #management
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
Women with in HIV-AIDS ... known to have HIV ... diagnosed with HIV ... Prevention #Treatment #management ... opportunistic #infections #HIVAIDS
Protease Inhibitors 

Protease Inhibitors are a class of commonly used antiretroviral medications for management of HIV.
medications for management ... of HIV. ... responsible for HIV ... These are always "boosted ... Protease #Inhibitors #HIV
Bell's Palsy - Diagnosis and Management Summary - GrepMed Handbook

Acute Idiopathic Unilateral Facial Nerve (CN7) Palsy
Presentation:
Diagnosis and Management ... Isolated lower, bilateral ... (Ramsay-Hunt), HIV ... delayed recovery Management ... Palsy #Diagnosis #Management
HIV Antiretroviral Regimen Components 
Dual NRTI Backbone + Third Agent 

The general HIV antiretroviral medication regimen
HIV Antiretroviral ... The general HIV ... either an INSTI, Boosted ... Regimens #Components #HIV ... #Pharmacology #Management
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
Leishmaniasis in HIV-AIDS ... amphotericin B 2–4 mg/kg IV ... amphotericin B 2–4 mg/kg IV ... Prevention #Treatment #management ... opportunistic #infections #HIVAIDS
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
Infections in HIV-AIDS ... PO (or 400 mg IV ... PO (or 400 mg IV ... Prevention #Treatment #management ... opportunistic #infections #HIVAIDS
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
Infections in HIV-AIDS ... to 5 mg/kg/day IV ... Prevention #Treatment #management ... opportunistic #infections #HIVAIDS
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
Candidiasis in HIV-AIDS ... 400 mg) PO or IV ... Prevention #Treatment #management ... opportunistic #infections #HIVAIDS